Onset of Lichen Planopilaris During Treatment with Etanercept

The document reported the onset of lichen planopilaris (LPP) in a patient undergoing treatment with etanercept, a TNF-alpha inhibitor. The case highlighted a potential adverse effect of etanercept, which is commonly used to treat autoimmune conditions. The authors suggested that clinicians should be aware of this possible side effect when prescribing etanercept, although the exact mechanism linking the drug to LPP remained unclear. The study emphasized the need for further research to understand the relationship between TNF-alpha inhibitors and the development of LPP.